MarketPeel
Insider Trading Intelligence
JR

Joshua Reed

ALDX
CHIEF FINANCIAL OFFICER · ALDEYRA THERAPEUTICS, INC. · CIK 0001746541
FILING MIX · LIFETIME83%/17%
BUYS
20
SELLS
4
TOTAL VALUE
$324.5K
COMPANIES
3
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
360,773
AVG SELL PX
$38.39
TRADE KIND
SHOWING 24 / 24
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Joshua Reed, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+14.78%+0.51%+14.27%+14.27%
14d2+0.00%+11.66%+2.32%+9.34%+9.34%
30d2+0.00%+20.01%+4.21%+15.79%+15.79%
60d2+0.00%+24.30%+7.95%+16.35%+16.35%
90d2+0.00%+15.52%+9.59%+5.93%+5.93%
180d2+0.00%+38.98%+14.40%+24.57%+24.57%
1y2+0.00%+69.70%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ALDX · 274,825 shares · as of Mar 30, 2022
071,444142,887214,331285,77420212022SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 20 buys / 4 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SRRK
SCHOLAR ROCK HOLDING CORP
SALE10b5-1
10b5-1 plan
948$54.28$51.5K19,518Jul 1, 2026Jul 6, 2026View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE10b5-1
10b5-1 plan
2,105$53.50$112.6K20,466Jul 1, 2026Jul 6, 2026View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
4,3104,310Jun 4, 2026Jun 8, 2026View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
6,83922,571Jun 4, 2026Jun 8, 2026View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
30,85430,854Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
66,43066,430Mar 2, 2026Mar 4, 2026View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
36,65636,656Oct 8, 2025Oct 10, 2025View →
ALKS
ALKERMES PLC.
PURCHASEGRANT
Stock grant
158,743158,743Oct 8, 2025Oct 10, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE10b5-1
10b5-1 plan
500$30.04$15.0K15,732May 29, 2025May 30, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
SALE10b5-1
10b5-1 plan
4,900$29.68$145.4K16,232May 29, 2025May 30, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
9,2069,206May 22, 2025May 23, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
7,63221,132May 22, 2025May 23, 2025View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
13,50013,500Jun 27, 2024Jul 1, 2024View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
18,00018,000Jun 27, 2024Jul 1, 2024View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
36,00036,000Jun 21, 2023Jun 22, 2023View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
28,00028,000May 26, 2022May 27, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Mar 30, 2022Apr 1, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
93,322274,825Mar 30, 2022Apr 1, 2022View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
150,185150,185Apr 12, 2021Apr 14, 2021View →
SRRK
SCHOLAR ROCK HOLDING CORP
PURCHASEGRANT
Stock grant
15,60015,600Mar 16, 2021Mar 18, 2021View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
137,707137,707Mar 2, 2020Mar 4, 2020View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
137,707173,481Mar 2, 2020Mar 6, 2020View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000285,774Mar 2, 2020Mar 4, 2020View →
ALDX
ALDEYRA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
250,000250,000Mar 2, 2020Mar 6, 2020View →
Other insiders · ALDX
Loading peer insiders…
About this filer
CIK 0001746541
ROLE
Chief Financial Officer
PRIMARY
ALDX
COMPANIES
3
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001746541DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback